Vagus Nerve Stimulation + Rehabilitation for Spinal Cord Injury

RK
AM
Overseen ByAlyssa Miller
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center, Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether vagus nerve stimulation (VNS) can be safely and effectively combined with rehabilitation for people with spinal cord injuries. The trial includes two groups: one receives VNS during therapy sessions, while the other receives a sham (inactive) version. It targets individuals who have experienced a traumatic spinal cord injury in the neck area for over a year and can still move their upper limbs slightly, such as pinching with their fingers. The goal is to determine if VNS can improve recovery when added to regular rehabilitation exercises. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance rehabilitation outcomes for spinal cord injuries.

Will I have to stop taking my current medications?

The trial does not specify if you must stop taking your current medications, but it excludes those on medication that may interfere with the study. It's best to discuss your specific medications with the trial team.

What prior data suggests that vagus nerve stimulation is safe for spinal cord injury rehabilitation?

Research shows that vagus nerve stimulation (VNS) is generally safe for people. Studies have found that combining VNS with rehabilitation is safe for those with spinal cord injuries. One study examined the safety and feasibility of combining VNS with rehabilitation therapy and found it to be both safe and feasible. Another study assessed the safety of VNS using a device called the ReStore system and found it well-tolerated.

While VNS is usually safe, some participants in these studies experienced mild side effects, such as hoarseness, coughing, or a slight tingling sensation. Overall, the evidence suggests that VNS is a safe option for those considering participation in a clinical trial for spinal cord injury rehabilitation.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about this trial because it explores the potential of Vagus Nerve Stimulation (VNS) paired with rehabilitation for spinal cord injury recovery. Unlike traditional treatments that focus solely on physical therapy, this approach combines targeted rehabilitation exercises with electrical stimulation of the vagus nerve, aiming to enhance neuroplasticity and improve motor function. This unique method could offer a more effective recovery process, potentially accelerating progress and improving outcomes for patients with spinal cord injuries. By integrating VNS, the trial seeks to unlock new pathways for healing that current standard care options, which typically rely on physical therapy alone, do not address.

What evidence suggests that pairing vagus nerve stimulation with rehabilitation could be effective for spinal cord injury?

Research has shown that combining vagus nerve stimulation (VNS) with rehabilitation can improve movement. In this trial, participants in the treatment group will receive active VNS paired with rehabilitation therapy, which previous studies have shown leads to significant improvements in arm and hand movement for people with spinal cord injuries. Meanwhile, the control group will receive sham VNS with rehabilitation therapy. Studies on stroke patients have also found that VNS with rehab aids in movement recovery, suggesting that VNS might help people regain movement after nerve-related injuries. The treatment stimulates the vagus nerve, enhancing the brain's ability to heal and reorganize itself. This makes VNS a promising option for improving recovery after spinal cord injuries.12467

Who Is on the Research Team?

RK

Radha Korupolu, MD

Principal Investigator

The University of Texas Health Science Center, Houston

Are You a Good Fit for This Trial?

This trial is for individuals at least 12 months post-traumatic cervical spinal cord injury (C8 and above), with some upper limb movement, like pinching. They must meet surgical criteria for VNS implantation. Excluded are those with non-traumatic SCI, vocal cord issues, significant brain injuries, prior vagus nerve damage, certain medications affecting neurotransmitters, other complicating conditions or surgeries, medical or mental instability, or pregnancy.

Inclusion Criteria

I am eligible for a VNS implant surgery as per my medical team.
I have a spinal cord injury in my neck that is not complete.
It has been over a year since my spinal cord injury.
See 1 more

Exclusion Criteria

I have a significant brain injury.
I am not on medication that affects how VNS works on my brain chemicals.
Medical or mental instability
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 18 goal-directed upper extremity rehabilitation therapy sessions with paired or sham VNS over six weeks

6 weeks
18 visits (in-person)

Home Exercise Program

Participants engage in a daily, 30-minute home therapy program

90 days

Follow-up

Participants are monitored for safety and effectiveness after treatment

90 days
3 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Active VNS
  • Arm rehabilitation
  • Sham VNS
Trial Overview The study tests the safety and effectiveness of pairing vagus nerve stimulation (VNS) with arm rehabilitation to improve upper extremity function in people with cervical spinal cord injury. Participants will receive either active VNS or a sham procedure alongside their rehabilitation exercises.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Treatment groupExperimental Treatment2 Interventions
Group II: Control GroupPlacebo Group2 Interventions

Active VNS is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as VNS Therapy for:
🇪🇺
Approved in European Union as VNS Therapy for:
🇨🇦
Approved in Canada as VNS Therapy for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials
974
Recruited
361,000+

MicroTransponder Inc.

Industry Sponsor

Trials
8
Recruited
1,300+

Published Research Related to This Trial

Closed-loop vagus nerve stimulation (CLV) significantly enhances recovery of forelimb function in rats after chronic spinal cord injury (SCI), outperforming rehabilitation alone.
CLV works by strengthening synaptic connections in the brain that control movement, and its benefits continue even after stimulation ends, indicating lasting improvements in neural circuit connectivity.
Closed-loop neuromodulation restores network connectivity and motor control after spinal cord injury.Ganzer, PD., Darrow, MJ., Meyers, EC., et al.[2019]
Electrical spinal cord stimulation (SCS) shows promise in improving autonomic functions related to exercise, particularly in individuals with spinal cord injuries, as evidenced by a review of 19 studies.
While improvements in blood pressure regulation were systematically studied, other benefits like temperature regulation and metabolism were mostly anecdotal, indicating a need for further research to optimize SCS parameters and locations for enhancing sympathetic functions.
Spinal electrical stimulation to improve sympathetic autonomic functions needed for movement and exercise after spinal cord injury: a scoping clinical review.Flett, S., Garcia, J., Cowley, KC.[2022]
Intermittent vagus nerve stimulation (VNS) was found to be safe in a rat model of chronic spinal cord injury (SCI), showing only temporary effects on heart rate without causing prolonged hypotension or exacerbating autonomic dysreflexia.
The study suggests that VNS could enhance recovery and promote plasticity in neurological disorders, warranting further research into its therapeutic potential following SCI.
Acute Cardiovascular Responses to Vagus Nerve Stimulation after Experimental Spinal Cord Injury.Sachdeva, R., Krassioukov, AV., Bucksot, JE., et al.[2022]

Citations

Closed-loop vagus nerve stimulation aids recovery from ...Decades of research have demonstrated that recovery from serious neurological injury will require synergistic therapeutic approaches.
VNS Clinical Trial Shows Improvements for Spinal Cord InjuriesThis approach, called closed-loop vagus nerve stimulation (CLV), produced meaningful improvements in arm and hand function in these individuals.
Vagus Nerve Stimulation (VNS) in Spinal Cord Injury (SCI) ...This study is an open label extension of the SCI EFS clinical trial (NCT04288245) that developed an innovative strategy to enhance recovery of motor and ...
Safety and feasibility of paired vagus nerve stimulation with ...Pairing vagus nerve stimulation with traditional rehabilitation therapies results in improved motor recovery in people with stroke.
5.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38872818/
Neurorehabilitation with vagus nerve stimulation: a systematic ...Our review suggests that VNS (non-invasive or invasive) paired with rehabilitation can improve motor outcomes after stroke in humans.
SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED)This study was designed to confirm the efficacy and safety of vagus nerve stimulation established in the controlled portion of the E-03 Study. Two weeks ...
7.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39610700/
Safety and feasibility of paired vagus nerve stimulation with ...Safety and feasibility of paired vagus nerve stimulation with rehabilitation for improving upper extremity function in people with cervical spinal cord injury: ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security